Similar articles

• Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils.

  Fiore S, Romano M, Serhan CN. Fiore S, et al. Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:93-6. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1825593 No abstract available.
• Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA.

  Levy BD, Bertram S, Tai HH, Israel E, Fischer A, Drazen JM, Serhan CN. Levy BD, et al. Lipids. 1993 Dec;28(12):1047-53. doi: 10.1007/BF02537069. Lipids. 1993. PMID: 8121246 Clinical Trial.
• Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.

  Chiang N, Takano T, Clish CB, Petasis NA, Tai HH, Serhan CN. Chiang N, et al. J Pharmacol Exp Ther. 1998 Nov;287(2):779-90. J Pharmacol Exp Ther. 1998. PMID: 9808710
• Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 modulate adhesion molecule expression on human leukocytes in whole blood and inhibit neutrophil-endothelial cell adhesion.

  Filep JG, Zouki C, Petasis NA, Hachicha M, Serhan CN. Filep JG, et al. Adv Exp Med Biol. 2002;507:223-8. doi: 10.1007/978-1-4615-0193-0_34. Adv Exp Med Biol. 2002. PMID: 12664589 Review. No abstract available.
• Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators.

  Serhan CN, Takano T, Gronert K, Chiang N, Clish CB. Serhan CN, et al. Clin Chem Lab Med. 1999 Mar;37(3):299-309. doi: 10.1515/CCLM.1999.052. Clin Chem Lab Med. 1999. PMID: 10353476 Review.